US$ 22.73
dpp4 and glp 1 together used GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? DPP-4 inhibitors in the treatment
Description
J.Tang-ChristensenM.HolstJ

Gao C, Liu Y, Jiang Y, Ding J, Li L

Gasoyan H, Pfoh ER, Schulte R, Le P, Rothberg MB
Patients should be assessed individually to determine the most appropriate agent based on their clinical needs, treatment goals, and ability to adhere to the prescribed regimen

Historic examples of such a co-administration therapy for the treatment of obesity include the famous rainbow pills [878]

Understanding those mechanisms is the first step toward strategies that actually work for you
